Consun Pharmaceutical Group Limited (01681) disclosed a Next Day Disclosure Return indicating that as of 27 October 2025, the company’s total number of issued shares remains at 847,973,407. Information in the document shows a series of repurchases from 14 October 2025 to 27 October 2025, amounting to 2,211,000 shares scheduled for cancellation but not yet cancelled as of the closing date. The highest repurchase price recorded during the period was HKD 15.7565, and the lowest was HKD 14.9148.

On 27 October 2025, 100,000 shares were repurchased on the Exchange at HKD 15.4 per share, with an aggregate consideration of HKD 1,540,000. According to the repurchase mandate granted on 22 May 2025, the company is authorized to repurchase up to 85,126,334 shares. A total of 7,406,000 shares have been repurchased so far, representing approximately 8.7% of the total number of issued shares as at the date of that resolution.